Neurocrine Biosciences (NBIX) Stock Chart & Stock Price History $138.43 +1.74 (+1.27%) (As of 12:45 PM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Neurocrine Biosciences Stock Price Performance 5 Day Performance+9.50%1 Month Performance+17.96%3 Month Performance+15.76%6 Month Performance+6.02%Year-To-Date Performance+5.30%1 Year Performance+15.69% Receive NBIX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neurocrine Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Do this Before Elon’s Reveal on January 22nd (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. NBIX Stock Chart for Wednesday, December, 18, 2024 NBIX Chart by TradingView Neurocrine Biosciences Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/17/2024$133.05$136.69+2.74%$137.24$132.101.58 million shs$13.84 billion12/16/2024$126.70$133.05+5.01%$134.81$127.351.65 million shs$13.47 billion12/13/2024$126.79$126.70-0.07%$127.05$125.61777,757 shs$12.83 billion12/12/2024$128.22$126.79-1.12%$128.63$126.63553,516 shs$12.84 billion12/11/2024$128.96$128.22-0.57%$129.68$127.29725,287 shs$12.98 billion12/10/2024$129.12$128.96-0.12%$130.48$127.58803,361 shs$13.06 billion Get the Latest News and Ratings for NBIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Neurocrine Biosciences and its competitors with MarketBeat's FREE daily newsletter. 12/09/2024$128.14$129.12+0.76%$129.42$128.02682,433 shs$13.07 billion12/06/2024$126.42$128.14+1.36%$128.93$126.96547,973 shs$12.97 billion12/05/2024$127.74$126.42-1.03%$127.82$125.74540,445 shs$12.80 billion12/04/2024$125.44$127.74+1.83%$127.90$125.21647,074 shs$12.93 billion12/03/2024$125.89$125.44-0.36%$126.72$125.26751,295 shs$12.70 billion12/02/2024$126.75$125.89-0.68%$128.00$125.76819,741 shs$12.75 billion11/29/2024$126.59$126.75+0.13%$127.07$125.50403,268 shs$12.83 billion11/28/2024$126.59$126.59$128.27$125.43739,665 shs$12.82 billion11/27/2024$127.91$126.59-1.03%$128.27$125.43739,665 shs$12.82 billion11/26/2024$127.11$127.91+0.63%$128.14$124.23756,984 shs$12.95 billion11/25/2024$125.65$127.11+1.16%$127.81$125.011.56 million shs$12.87 billion11/22/2024$125.00$125.65+0.52%$127.00$124.381.21 million shs$12.72 billion11/21/2024$123.29$125.00+1.39%$126.13$122.371.20 million shs$12.66 billion11/20/2024$119.13$123.29+3.49%$124.01$118.911.40 million shs$12.48 billion11/19/2024$117.62$119.13+1.28%$119.79$115.271.09 million shs$12.06 billion11/18/2024$117.44$117.62+0.15%$118.32$116.331.05 million shs$11.91 billion Related Companies Alnylam Pharmaceuticals Stock Chart Biogen Stock Chart United Therapeutics Stock Chart Incyte Stock Chart BioMarin Pharmaceutical Stock Chart Exact Sciences Stock Chart Exelixis Stock Chart Repligen Stock Chart Madrigal Pharmaceuticals Stock Chart Halozyme Therapeutics Stock Chart Receive NBIX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neurocrine Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NBIX) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored“The Last Retirement Stock You’ll Ever Need”We've just released a critical trade alert about a groundbreaking AI investment opportunity. So, I wanted t...Behind the Markets | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | SponsoredBitcoin is going to $100,000 … before Inauguration DayMark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neurocrine Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neurocrine Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NBIX Stock Alerts